knowcompoundssodium(1+)
Specimen compound element, as a monatomic cation
Sodium
A monoatomic monocation obtained from sodium.”
- Formula
- Na+
- Molar mass
- 22.99 g/mol
- ChEBI
- CHEBI:29101
- InChIKey
- FKNQFGJONOIPTF-UHFFFAOYSA-N
↑ raised 1 finding in 1 endpoint · ↓ lowered 3 in 3 · – no difference found 5 in 4
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 2
- Limited
- 1
- Very limited
- 6
- Insufficient
- 0
Sodium
Most findings
- All-cause mortality×2
- Body mass×1
- Expanded Disability Status Scale (EDSS)×1
- Peak postprandial blood glucose×1
Show the remaining 4Show the first 4
- Core body temperature×1
- Rating of perceived exertion×1
- Serum creatinine concentration×1
- Serum sodium concentration×1
1,230 reference statements, not drawn · 36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- All-cause mortality
- Peak postprandial blood glucose
- Expanded Disability Status Scale (EDSS)
- Body mass
- Core body temperature
- Rating of perceived exertion
- Serum creatinine concentration
- Serum sodium concentration
02 · findings
What sodium moved, and by how much
- RR risk ratio · MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
9 shown
- All-cause mortalityMoved: no difference foundEffect, as reportedRR1.02[0.93 to 1.12]Evidence: Moderatereplicated ×1Paper: PMID 303405412018
- Who
- Adults in 8 prospective cohort studies reporting total mortality, sodium intake assessed by 24 h urine collection or food frequency questionnaire; per 100 mmol/day increment in sodium intake
- Dose studied
- 100 mmol/day increment in sodium intake (observational gradient)
However, the results did not reveal any significant association of 100 mmol increments per day in sodium intake with the total mortality risk (RR: 1.02; 95% CI: 0.93–1.12; P = 0.720; Fig. 2b).”
Quoted verbatim from Association of sodium intake and major cardiovascular outcomes: a dose-response meta-analysis of prospective cohort studies.meta-analysisPermalink - Peak postprandial blood glucoseMoved: lowersEffect, as reportedMD−0.481[−0.88 to −0.083]Evidence: ModeratePaper: PMID 413134322026An author is affiliated with a producer
- Who
- Eleven adults without diabetes, at least 12 months after Roux-en-Y gastric bypass; mixed meal tolerance test (orange juice and yoghurt) with versus without added NaCl
- Dose studied
- 2 g additional NaCl (about 785 mg sodium) dissolved in 170 mL orange juice, single mixed meal tolerance test, versus the same meal without added NaCl
NaCl supplementation resulted in 6% lower peak plasma glucose (mean difference − 0.481 mmol/L, 95% CI: -0.880 to -0.083 mmol/L, p = 0.022).”
Quoted verbatim from The Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass: a Proof-of-Concept, Randomized, Open-Label, Crossover Study.crossoverPermalink - Expanded Disability Status Scale (EDSS)Moved: no difference foundEvidence: LimitedPaper: PMID 285564982017
- Who
- 465 patients with a clinically isolated syndrome in the BENEFIT trial; exposure is estimated 24-hour urine sodium (Tanaka equations) from repeated spot urines, per 1 g increase, not an assigned dose
- Dose studied
- not reported
Average 24-hour urine sodium levels were not associated with conversion to clinically definite MS over the 5-year follow-up (hazard ratio [HR] = 0.91, 95% confidence interval [CI] = 0.67-1.24 per 1g increase in estimated daily sodium intake), nor were they associated with clinical or MRI outcomes (new active lesions after 6 months: HR = 1.05, 95% CI = 0.97-1.13; relative change in T2 lesion volume: -0.11, 95% CI = -0.25 to 0.04; change in EDSS: -0.01, 95% CI = -0.09 to 0.08; relapse rate: HR = 0.78, 95% CI = 0.56-1.07).”
Quoted verbatim from Sodium intake and multiple sclerosis activity and progression in BENEFIT.cohortPermalink - Body massMoved: lowersEffect, as reportedMD−2.48[−4.31 to −0.66]Evidence: Very limitedPaper: PMID 404505752025
- Who
- Patients hospitalized for acute decompensated heart failure; supplemental sodium plus furosemide versus furosemide alone (furosemide in both arms); oral and intravenous sodium trials pooled
- Dose studied
- not reported
Supplemental sodium with furosemide significantly decreased serum creatinine (pooled net mean difference [NMD]: -0.33 mg/dL, 95% confidence interval [CI]: [-0.50 to -0.17]), brain natriuretic peptide (pooled NMD: -62.84 pg/mL, 95% CI: [-103.61 to -22.08]), and weight (pooled NMD: -2.48 kg, 95% CI: [-4.31 to -0.66]).”
Quoted verbatim from Prescribed in-hospital sodium intake for decompensated heart failure: A systematic review and meta-analysis.meta-analysisPermalink - Serum creatinine concentrationMoved: lowersEffect, as reportedMD−0.33[−0.5 to −0.17]Evidence: Very limitedPaper: PMID 404505752025
- Who
- Patients hospitalized for acute decompensated heart failure; supplemental sodium plus furosemide versus furosemide alone (furosemide in both arms); oral and intravenous sodium trials pooled
- Dose studied
- not reported
Supplemental sodium with furosemide significantly decreased serum creatinine (pooled net mean difference [NMD]: -0.33 mg/dL, 95% confidence interval [CI]: [-0.50 to -0.17]), brain natriuretic peptide (pooled NMD: -62.84 pg/mL, 95% CI: [-103.61 to -22.08]), and weight (pooled NMD: -2.48 kg, 95% CI: [-4.31 to -0.66]).”
Quoted verbatim from Prescribed in-hospital sodium intake for decompensated heart failure: A systematic review and meta-analysis.meta-analysisPermalink - All-cause mortalityMoved: no difference foundEvidence: Very limitedreplicated ×1Paper: PMID 303459502019
- Who
- Adults in prospective cohort studies; dose-response of dietary sodium (Na) intake per 100 mg/day increment
- Dose studied
- 100 mg/day increment in Na intake (observational gradient)
No linear association (effect size; 95 % CI; I 2) was seen between 100mg/d increment in Na intake and CVD mortality (1·01; 0·97, 1·05; 98·4 %) or all-cause mortality (1·01; 1·00, 1·02; 89·2 %).”
Quoted verbatim from Dose-response association of dietary sodium intake with all-cause and cardiovascular mortality: a systematic review and meta-analysis of prospective studies.meta-analysisPermalink - Core body temperatureMoved: no difference foundEvidence: Very limitedPaper: PMID 379445072024
- Who
- Nine healthy participants (7 male, 2 female) during two 5-hour treadmill runs at 30°C
- Dose studied
- sodium chloride capsules replacing 100% of previously assessed sweat sodium losses, during a 5-hour run; placebo comparator
No effect of sodium replacement was observed for heart rate, rectal temperature, thermal comfort, perceived exertion, or physiological strain index.”
Quoted verbatim from Effect of Personalized Sodium Replacement on Fluid and Sodium Balance and Thermophysiological Strain During and After Ultraendurance Running in the Heat.crossoverPermalink - Rating of perceived exertionMoved: no difference foundEvidence: Very limitedPaper: PMID 379445072024
- Who
- Nine healthy participants (7 male, 2 female) during two 5-hour treadmill runs at 30°C
- Dose studied
- sodium chloride capsules replacing 100% of previously assessed sweat sodium losses, during a 5-hour run; placebo comparator
No effect of sodium replacement was observed for heart rate, rectal temperature, thermal comfort, perceived exertion, or physiological strain index.”
Quoted verbatim from Effect of Personalized Sodium Replacement on Fluid and Sodium Balance and Thermophysiological Strain During and After Ultraendurance Running in the Heat.crossoverPermalink - Serum sodium concentrationMoved: raisesEvidence: Very limitedPaper: PMID 379445072024
- Who
- Nine healthy participants (7 male, 2 female) during two 5-hour treadmill runs in the heat; change in plasma sodium at 2.5 hours and postexercise
- Dose studied
- sodium chloride capsules replacing 100% of previously assessed sweat sodium losses, during a 5-hour run; placebo comparator
Plasma sodium concentration increased in both trials, but to a greater extent in SODIUM at 2.5 hours (mean [SD]: 4 [4] mmol·L-1 vs 1 [5] mmol·L-1; P < .05) and postexercise (4 [3] mmol·L-1 vs 1 [5] mmol·L-1; P < .05).”
Quoted verbatim from Effect of Personalized Sodium Replacement on Fluid and Sodium Balance and Thermophysiological Strain During and After Ultraendurance Running in the Heat.crossoverPermalink
No row matches these filters.
No dose is advised.
- RR risk ratio · MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
03 · identity
Structure
- Atomic radius
- 180 pm
- Ionic radius, Na⁺
- 102 pm
- Electronegativity
- 0.93 Pauling
- Charge
- +1
- SMILES
- [Na+]
04 · reach
What it touches on the way
40 entities · assembled from reference reactions
- SLC38A2Protein2,556 paths · 136 endpointsinferred
- SLC1A3Protein349 paths · 51 endpointsinferred
- SLC1A2Protein334 paths · 42 endpointsinferred
- SLC1A5Protein325 paths · 20 endpointsinferred
- ATP1A1Protein297 paths · 149 endpointsinferred
- SLC6A6Protein193 paths · 25 endpointsinferred
- SLC6A1Protein170 paths · 43 endpointsinferred
- SLC10A6Protein165 paths · 11 endpointsinferred
- ATP1A2Protein139 paths · 73 endpointsinferred
- SLC27A3Protein128 paths · 16 endpointsinferred
- SLC6A8Protein108 paths · 54 endpointsinferred
- AQP1Protein98 paths · 97 endpointsinferred
Show the remaining 28Show the first 12
Every entity, on one pageWhere it reaches
28 regions · transporter routes
- Brainnervous50 routesinferred
- Male reproductivereproductive32 routesinferred
- Female reproductivereproductive31 routesinferred
- Blood vesselscardiovascular21 routesinferred
- Colon and rectumdigestive21 routesinferred
- Heartcardiovascular21 routesinferred
- Mouth and oesophagusdigestive21 routesinferred
- Nerve and spinal cordnervous21 routesinferred
- Blood and immuneimmune18 routesinferred
- Small intestinedigestive18 routesinferred
- Airway and sinusesrespiratory17 routesinferred
- Eyenervous17 routesinferred
Show the remaining 16Show the first 12
- Lungrespiratory15 routesinferred
- Pancreasendocrine15 routesinferred
- Thyroidendocrine15 routesinferred
- Skeletal musclemusculoskeletal14 routesinferred
- Skinintegumentary14 routesinferred
- Stomachdigestive14 routesinferred
- Adrenal glandendocrine12 routesinferred
- Bladderurinary12 routesinferred
- Kidneyurinary11 routesinferred
- Bone and jointmusculoskeletal9 routesinferred
- Breastreproductive9 routesinferred
- Gallbladderdigestive6 routesinferred
- Liverdigestive6 routesinferred
- Spleenimmune6 routesinferred
- Adipose tissueintegumentary5 routesinferred
- Peritoneumdigestive4 routesinferred
What the reference databases state
1,230Reference statements
What the reference databases state
Evidence keyStatements
1,230 statements
sodium(1+) is transported by each · Sources: Human-GEM, Rhea
- ProteinHuman-GEM MAR11791Inferred only
- ProteinRhea RHEA:34963Inferred only
- ProteinRhea RHEA:34963Inferred only
- ProteinRhea RHEA:34963Inferred only
- ProteinRhea RHEA:34963Inferred only
- ProteinRhea RHEA:34963Inferred only
- ProteinRhea RHEA:34963Inferred only
- ProteinRhea RHEA:34963Inferred only
- ProteinHuman-GEM MAR01444 · Rhea RHEA:18353Inferred only
- ProteinHuman-GEM MAR05429 · Rhea RHEA:18353Inferred only
- ProteinRhea RHEA:18353 · Human-GEM MAR05429Inferred only
- ProteinRhea RHEA:18353 · Human-GEM MAR05429Inferred only
Show the next 110Show the first 12
300 of 1,230 statements listed here · all 1,230 through the API
830Reactions
06 · on the label · 15,564 products
Labelled products
Source: NIH DSLD · Ingredient: sodium(1+) · 15,564 products · Declared amount per serving (the first 1,000 shown): 0.1–3,120 mg · 2 amounts above the serving weight, left out
964 labels of the first 1,000 shown state an amount36 do not
- 21st CenturyMaximum Strength Glucosamine & Chondroitin Plus115 mgper 1 tabletDSLD:11284
- 21st CenturyMaximum Strength Glucosamine & Chondroitin Plus115 mgper 1 tabletDSLD:11286
- 21st Century Zoo FriendsComplete5 mgper 1 tabletDSLD:11637
- 360 NutritionApple Cider Vinegar Cleanse10 mgper 1 TbspDSLD:180144
- 360 NutritionTurmeric Cleanse5 mgper 1 TbspDSLD:180156
- Advanced Nutrition SystemsDAA Test-53,120 mgper 4 capsulesDSLD:180473
- Advanced Nutrition SystemsDAA Test-53,120 mgper 4 capsulesDSLD:180479
- Advanced Nutrition SystemsGalvanized + Ripped Lemon Lime IceSodium, as Sodium Chloride25 mgper 13.3 gDSLD:180566
- Advanced Nutrition SystemsGalvanized + Ripped Patriot PopSodium, as Sodium Chloride25 mgper 13.7 gDSLD:180561
- Advanced Nutrition SystemsGalvanized + Strength Blue Razz Sour Candy5 mgper 15.5 gDSLD:180488
- Advanced Nutrition SystemsGalvanized + Strength Wild Fruit Tarts5 mgper 15.3 gDSLD:180535
- Advanced Nutrition SystemsSurge 2.0 Fruit Punch5 mgper 22.1 gDSLD:180393
Show the remaining 15,552Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
07 · the record
Sources
330
papers screened for sodium
- admitted
- 7
- read and discarded
- 307
- not read yet
- 16
Sources cited
6 papers · 9 findings
1 admitted at screening, no finding yet
Show every paper citedHide the papers cited
Other names · 6
Na(+) · Na+ · SODIUM ION
systematic · sodium cation
systematic · sodium(1+) ion
systematic · sodium(I) cation